Response to Comment on: Butler et al. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? Diabetes Care 2013;36:2118

Response to Comment on: Butler et al. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? Diabetes Care 2013;36:2118–2125

Published:2013-11-13 Issue:12 Volume:36 Page:e214-e214
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Gale Edwin A.M.¹

Affiliation:

1. Department of Diabetes and Metabolism, Southmead Hospital, University of Bristol, Bristol, U.K.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/36/12/e214/614900/e214.pdf

Reference8 articles.

1. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe?;Butler;Diabetes Care,2013

2. Comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118–2125 (Letter);Bjerre Knudsen;Diabetes Care,2013

3. The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species;Nyborg;Diabetes,2012

4. The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis;Vrang;Am J Physiol Endocrinol Metab,2012

5. Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model;Gier;Diabetes,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development;Frontiers in Oncology;2021-08-16

2. The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes;Metabolism;2020-08

3. A Review of the Long-Term Efficacy, Tolerability, and Safety of Exenatide Once Weekly for Type 2 Diabetes;Advances in Therapy;2017-07-03